VRCI vs. YGEN, PRM, ABDX, GDR, GENI, IDHC, DMTR, LLAI, LLA, and DXRX
Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Proteome Sciences (PRM), Abingdon Health (ABDX), genedrive (GDR), GENinCode (GENI), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.
Verici Dx vs.
Verici Dx (LON:VRCI) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking.
Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.
51.9% of Verici Dx shares are owned by institutional investors. Comparatively, 23.3% of Yourgene Health shares are owned by institutional investors. 17.1% of Verici Dx shares are owned by company insiders. Comparatively, 64.4% of Yourgene Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Verici Dx has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500.
In the previous week, Verici Dx's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.
Yourgene Health received 17 more outperform votes than Verici Dx when rated by MarketBeat users.
Verici Dx has higher earnings, but lower revenue than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.
Summary
Yourgene Health beats Verici Dx on 7 of the 11 factors compared between the two stocks.
Get Verici Dx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verici Dx Competitors List
Related Companies and Tools
This page (LON:VRCI) was last updated on 2/22/2025 by MarketBeat.com Staff
